SUBSCRIBE
SUBSCRIBE

Phase 2

Drug Development
Informed Consent ‘Not up to Scratch’
July 19, 2007
 · 
1 min read
Drug Development
Clinical Drug Trials Put Thais ‘at Risk’
July 18, 2007
 · 
1 min read
Drug Development
Clinical Trials on a Naive Indian Audience Zoom
July 18, 2007
 · 
1 min read
Drug Development
Making Head Winds
January 4, 2007
 · 
6 min read
Drug Development
No Benefit For Liver Cancer Patients From Long-Acting Octreotide
January 3, 2007
 · 
1 min read
Business
The Day In Review: Artes Medical Inc. Sets IPO Terms
November 29, 2006
 · 
1 min read
Drug Development
The Day In Review: Targeted Genetics Corporation Soars While Biotech Falls
November 27, 2006
 · 
1 min read
Drug Development
The Day In Review: Mixed Results For New Merck & Co., Inc. COX-2 Drug
November 14, 2006
 · 
1 min read
Drug Development
The Day In Review: Merck & Co., Inc. Buys Sirna Therapeutics, Inc. For $1.1 Billion
October 30, 2006
 · 
1 min read
Drug Development
Antisoma PLC Lung Cancer Drug “Extends Life”
September 28, 2006
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Supporting Coordinated Modulation of Lipid Transport and Myelination Pathways
July 13, 2026
 · 
3 min read
Press Releases
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
July 13, 2026
 · 
12 min read
Press Releases
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
 · 
5 min read
Press Releases
As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
July 13, 2026
 · 
14 min read
Press Releases
Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress
July 13, 2026
 · 
7 min read
Press Releases
First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure
July 13, 2026
 · 
3 min read
Press Releases
Aligos Therapeutics Announces the Completion of Enrollment in the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium Under Development for the Treatment of Chronic HBV Infection
July 13, 2026
 · 
5 min read
Press Releases
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
 · 
9 min read
Press Releases
Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
July 13, 2026
 · 
8 min read
Press Releases
NeuroTherapia to Present Phase 2a Alzheimer’s Disease Clinical Data at the AAIC 2026 Conference in London, UK
July 13, 2026
 · 
4 min read
Press Releases
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 10, 2026
 · 
4 min read
Press Releases
LEO Pharma Announces Key Results of Phase 2 TRAPEDS-1 Trial Evaluating Pharmacokinetics and Safety of Tralokinumab in Children With Moderate-to-Severe Atopic Dermatitis
July 9, 2026
 · 
6 min read
Press Releases
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
July 9, 2026
 · 
4 min read
Press Releases
Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome
July 9, 2026
 · 
7 min read
Press Releases
CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
July 9, 2026
 · 
9 min read
Press Releases
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
July 9, 2026
 · 
7 min read
Press Releases
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
July 9, 2026
 · 
6 min read
Press Releases
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
July 9, 2026
 · 
3 min read
Press Releases
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
July 8, 2026
 · 
6 min read
Press Releases
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
July 8, 2026
 · 
6 min read
Load More